Delivra Health Brands (DHB) Stock Overview
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
DHB Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Delivra Health Brands Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.24 |
| 52 Week High | CA$0.37 |
| 52 Week Low | CA$0.11 |
| Beta | 1.56 |
| 1 Month Change | 26.32% |
| 3 Month Change | 0% |
| 1 Year Change | 20.00% |
| 3 Year Change | -4.00% |
| 5 Year Change | -60.00% |
| Change since IPO | -96.67% |
Recent News & Updates
Delivra Health Brands (CVE:DHB) Has Debt But No Earnings; Should You Worry?
Oct 09
Is Delivra Health Brands (CVE:DHB) A Risky Investment?
Sep 05Recent updates
Delivra Health Brands (CVE:DHB) Has Debt But No Earnings; Should You Worry?
Oct 09Is Delivra Health Brands (CVE:DHB) A Risky Investment?
Sep 05Health Check: How Prudently Does Delivra Health Brands (CVE:DHB) Use Debt?
May 08
CA Pharmaceuticals Firm Will Boost Competitive Edge Through R&D And Market Expansion
Expansion into new geographies and enhanced customer loyalty aims to boost revenue and diversify revenue streams for growth.Delivra Health Brands Inc.'s (CVE:DHB) Business Is Trailing The Market But Its Shares Aren't
Jan 23Health Check: How Prudently Does Harvest One Cannabis (CVE:HVT) Use Debt?
May 29Did The Underlying Business Drive Harvest One Cannabis' (CVE:HVT) Lovely 345% Share Price Gain?
Feb 11Shareholder Returns
| DHB | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -17.2% | -5.8% | -1.7% |
| 1Y | 20.0% | -14.3% | 18.8% |
Return vs Industry: DHB exceeded the Canadian Pharmaceuticals industry which returned -14.3% over the past year.
Return vs Market: DHB underperformed the Canadian Market which returned 18.8% over the past year.
Price Volatility
| DHB volatility | |
|---|---|
| DHB Average Weekly Movement | 18.1% |
| Pharmaceuticals Industry Average Movement | 12.6% |
| Market Average Movement | 9.4% |
| 10% most volatile stocks in CA Market | 20.3% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: DHB's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: DHB's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Gord Davey | delivrahealthbrands.com |
Delivra Health Brands Inc., through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide. It offers liquid sleep shots, gummies, and sleep powder packets, as well as pain relief creams under the Dream Water, LivRelief, and Dream Water brands. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.
Delivra Health Brands Inc. Fundamentals Summary
| DHB fundamental statistics | |
|---|---|
| Market cap | CA$7.50m |
| Earnings (TTM) | -CA$1.19m |
| Revenue (TTM) | CA$13.37m |
Is DHB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DHB income statement (TTM) | |
|---|---|
| Revenue | CA$13.37m |
| Cost of Revenue | CA$6.59m |
| Gross Profit | CA$6.78m |
| Other Expenses | CA$7.97m |
| Earnings | -CA$1.19m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.038 |
| Gross Margin | 50.70% |
| Net Profit Margin | -8.90% |
| Debt/Equity Ratio | 49.8% |
How did DHB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/14 19:40 |
| End of Day Share Price | 2025/10/10 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Delivra Health Brands Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Siddharth Rajeev | Fundamental Research Corp. |
| Neal Gilmer | Haywood Securities Inc. |
| Greg McLeish | Research Capital Corporation |